ABCC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 11 | Predicted membrane proteins
| | | | | Tissue enhanced |
AKNAD1 | AKNA domain containing 1 | | | | | | Tissue enhanced |
ANKEF1 | Ankyrin repeat and EF-hand domain containing 1 | | | | | | Tissue enhanced |
ANKRD45 | Ankyrin repeat domain 45 | | | | | | Tissue enhanced |
ANO2 | Anoctamin 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AQP5 | Aquaporin 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ARHGAP28 | Rho GTPase activating protein 28 | | | | | | Tissue enhanced |
ARHGEF33 | Rho guanine nucleotide exchange factor (GEF) 33 | | | | | | Tissue enhanced |
ASB9 | Ankyrin repeat and SOCS box containing 9 | | | | | | Tissue enhanced |
ASRGL1 | Asparaginase like 1 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ATP7B | ATPase, Cu++ transporting, beta polypeptide | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AUNIP | Aurora kinase A and ninein interacting protein | | | | | | Tissue enhanced |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
BUB1 | BUB1 mitotic checkpoint serine/threonine kinase | Enzymes
| | | | | Tissue enhanced |
BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
C10orf115 | Chromosome 10 open reading frame 115 | | | | | | Tissue enhanced |
C11orf63 | Chromosome 11 open reading frame 63 | | | | | | Tissue enhanced |
C12orf56 | Chromosome 12 open reading frame 56 | | | | | | Tissue enhanced |
C12orf60 | Chromosome 12 open reading frame 60 | | | | | | Tissue enhanced |
C14orf39 | Chromosome 14 open reading frame 39 | Plasma proteins
| | | | | Tissue enhanced |
C16orf46 | Chromosome 16 open reading frame 46 | | | | | | Tissue enhanced |
C17orf53 | Chromosome 17 open reading frame 53 | | | | | | Tissue enhanced |
C17orf97 | Chromosome 17 open reading frame 97 | | | | | | Tissue enhanced |
C18orf54 | Chromosome 18 open reading frame 54 | Predicted secreted proteins
| | | | | Tissue enhanced |
C19orf57 | Chromosome 19 open reading frame 57 | | | | | | Tissue enhanced |
C19orf81 | Chromosome 19 open reading frame 81 | | | | | | Tissue enhanced |
C1orf222 | Chromosome 1 open reading frame 222 | | | | | | Tissue enhanced |
C2orf88 | Chromosome 2 open reading frame 88 | | | | | | Tissue enhanced |
C6orf52 | Chromosome 6 open reading frame 52 | | | | | | Tissue enhanced |
C9orf147 | Chromosome 9 open reading frame 147 | | | | | | Tissue enhanced |
CALB2 | Calbindin 2 | Plasma proteins
| | | | | Tissue enhanced |
CAMK4 | Calcium/calmodulin-dependent protein kinase IV | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
CBX2 | Chromobox homolog 2 | Disease related genes
| | | | | Tissue enhanced |
CCDC112 | Coiled-coil domain containing 112 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCDC15 | Coiled-coil domain containing 15 | | | | | | Tissue enhanced |
CCDC178 | Coiled-coil domain containing 178 | | | | | | Tissue enhanced |
CCDC181 | Coiled-coil domain containing 181 | | | | | | Tissue enhanced |
CCDC39 | Coiled-coil domain containing 39 | Cytoskeleton related proteins Disease related genes
| | | | | Tissue enhanced |
CCNB2 | Cyclin B2 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
CCNB3 | Cyclin B3 | | | | | | Tissue enhanced |
CDC25C | Cell division cycle 25C | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
CDC45 | Cell division cycle 45 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDCA2 | Cell division cycle associated 2 | | | | | | Tissue enhanced |
CDCA5 | Cell division cycle associated 5 | | | | | | Tissue enhanced |
CDKN3 | Cyclin-dependent kinase inhibitor 3 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
CENPU | Centromere protein U | | | | | | Tissue enhanced |
CLDN11 | Claudin 11 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLGN | Calmegin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CTD-2260A17.2 | Uncharacterized protein | | | | | | Tissue enhanced |